MH

MEGAN HERBER

FAEGRE DRINKER BIDDLE & REATH LLP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
11
last 3 years
Filings
23
14 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
Legislative Director/Senior Legislative Assistant/Legislative Assistant
Rep. Doris Matsui
D-CA
Disclosed on LD-2 filings
Legislative Director/Senior Legislative Assistant/Legislative Assistant
Rep. Doris Matsui
Disclosed on LD-2 filings
Legislative Director/Senior Legislative Assistant/Legislative Assistant
Rep. Doreis Matsui
D-CA
Disclosed on LD-2 filings
Press Secretary and Legislative Assistant
Rep. Christopher H. Smith
R-NJ
Disclosed on LD-2 filings
Legislative Director/Senior Legislative Assistant/Legislative Assistant
Rep. Doris Matsui (D-CA) 2014-2018
Disclosed on LD-2 filings
Legislative Director/Senior Legislative Assistant/LegislativeAssistant
Rep. Doris Matsui (D-CA) 2014-2018
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

FY 25 report language pertaining to primary immunodeficiency disease medical research.
Budget/Appropriations · 2024 Q3
Funding and related issue pertaining to improving diagnostics of PI; FDA proposal to regulate Laboratory Developed Tests (LDTs); H.R. 5397, the Joe Fiandra Access to Home Infusion Act.
Health Issues · 2024 Q3
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities
Medicare/Medicaid · 2024 Q3
Congressionally Directed Spending request; Federal funding for employment training and other services
Health Issues · 2024 Q3
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Pharmacy · 2024 Q3
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Health Issues · 2024 Q3

Clients

2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 1 filing
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q3
IMMUNE DEFICIENCY FOUNDATION
Q3lda.gov →
2024 Q3
NE HEALTHCARE SERVICES, INC.
RRlda.gov →
2024 Q3
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH)
Q3lda.gov →
2024 Q3
ATA ACTION
Q3lda.gov →
2024 Q3
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
Q3lda.gov →
2024 Q3
BOSTON CHILDREN'S HOSPITAL
Q3lda.gov →
2024 Q3
TURQUOISE HEALTH CO.
RRlda.gov →
2024 Q2
TEVA PHARMACEUTICALS USA, INC.
RRlda.gov →
2024 Q2
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
Q2lda.gov →
2024 Q2
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH)
Q2lda.gov →
2024 Q2
CIRCLE MEDICAL
2Tlda.gov →
2024 Q2
ATA ACTION
Q2lda.gov →
Showing recent filings · full history on lda.gov